Cargando…

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET

PURPOSE: This study aimed to investigate the uptake characteristics of (18)F-fluoromisonidazole (FMISO), in mutant-type isocitrate dehydrogenase (IDH-mutant, grade 3 and 4) and wild-type IDH (IDH-wildtype, grade 4) 2021 WHO classification adult-type diffuse gliomas. MATERIALS AND METHODS: Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yang, Fushimi, Yasutaka, Arakawa, Yoshiki, Shimizu, Yoichi, Sano, Kohei, Sakata, Akihiko, Nakajima, Satoshi, Okuchi, Sachi, Hinoda, Takuya, Oshima, Sonoko, Otani, Sayo, Ishimori, Takayoshi, Tanji, Masahiro, Mineharu, Yohei, Yoshida, Kazumichi, Nakamoto, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10613590/ https://www.ncbi.nlm.nih.gov/pubmed/37219717 http://dx.doi.org/10.1007/s11604-023-01450-x

Ejemplares similares

Accuracy, repeatability, and reproducibility of T(1) and T(2) relaxation times measurement by 3D magnetic resonance fingerprinting with different dictionary resolutions
por: Wicaksono, Krishna Pandu, et al.
Publicado: (2022)

Comparison of TGSE-BLADE DWI, RESOLVE DWI, and SS-EPI DWI in healthy volunteers and patients after cerebral aneurysm clipping
por: Okuchi, Sachi, et al.
Publicado: (2022)

Vessel wall MR imaging in neuroradiology
por: Fushimi, Yasutaka, et al.
Publicado: (2022)

Denoising approach with deep learning-based reconstruction for neuromelanin-sensitive MRI: image quality and diagnostic performance
por: Oshima, Sonoko, et al.
Publicado: (2023)

Quiet Diffusion-weighted MR Imaging of the Brain for Pediatric Patients with Moyamoya Disease
por: Nakajima, Satoshi, et al.
Publicado: (2021)

THER-07. INHIBITION OF THE RAS SIGNALING ENHANCES VIRAL ONCOLYSIS IN MALIGNANT GLIOMAS
por: Arakawa, Yoshiki, et al.
Publicado: (2020)

Clinical Application of MPRAGE Wave Controlled Aliasing in Parallel Imaging (Wave-CAIPI): A Comparative Study with MPRAGE GRAPPA
por: Sakurama, Azusa, et al.
Publicado: (2021)

Incidence of neurocutaneous melanosis in Japanese pediatric patients with congenital melanocytic nevi
por: Takiya, Miyuki, et al.
Publicado: (2023)

Biological characteristics of intratumoral [F-18]-fluoromisonidazole distribution in a rodent model of glioma
por: HATANO, TOSHIYUKI, et al.
Publicado: (2013)

Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy
por: Hattori, Etsuko Yamamoto, et al.
Publicado: (2023)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma
por: Mellinghoff, Ingo K., et al.
Publicado: (2020)

Infrequent RAS mutation is not associated with specific histological phenotype in gliomas
por: Makino, Yasuhide, et al.
Publicado: (2021)

Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
por: Liu, Yang, et al.
Publicado: (2020)

EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma
por: Taher, Mohiuddin M., et al.
Publicado: (2020)

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
por: Yan, Dongming, et al.
Publicado: (2022)

Adult isocitrate dehydrogenase–mutant brainstem glioma: illustrative case
por: Ye, Vincent C., et al.
Publicado: (2021)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
por: Gallus, Marco, et al.
Publicado: (2023)

Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
por: Huang, Juan, et al.
Publicado: (2019)

Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas
por: Neumaier, Felix, et al.
Publicado: (2023)

Isocitrate dehydrogenase mutations in gliomas: A review of current understanding and trials
por: Sharma, Nikhil, et al.
Publicado: (2023)

Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
por: Yamaguchi, Shigeru, et al.
Publicado: (2016)

Isocitrate dehydrogenase 1 mutation subtypes at site 132 and their translational potential in glioma
por: Lu, Victor M, et al.
Publicado: (2018)

Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients
por: Auezova, Raushan, et al.
Publicado: (2019)

Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma
por: Jia, Yanfei, et al.
Publicado: (2020)

Advanced multiparametric MRI-based scoring for isocitrate dehydrogenase mutation prediction of gliomas
por: Hosur, Bharat, et al.
Publicado: (2022)

Vorasidenib: A promising therapeutic breakthrough for diffuse isocitrate dehydrogenase mutant gliomas
por: Wahid, Abdul, et al.
Publicado: (2023)

Mechanisms underlying the biological changes induced by isocitrate dehydrogenase-1 mutation in glioma cells
por: WANG, JU-BO, et al.
Publicado: (2014)

Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas
por: Li, Ming-Yang, et al.
Publicado: (2015)

Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas
por: Wu, Shuang, et al.
Publicado: (2019)

Screening of Methylation Signature and Gene Functions Associated With the Subtypes of Isocitrate Dehydrogenase-Mutation Gliomas
por: Pan, XiaoYong, et al.
Publicado: (2019)

Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas
por: Wang, Lei-Ming, et al.
Publicado: (2019)

Isocitrate dehydrogenase (IDH) status prediction in histopathology images of gliomas using deep learning
por: Liu, Sidong, et al.
Publicado: (2020)

Grading Meningioma: A Comparative Study of Thallium-SPECT and FDG-PET
por: Okuchi, Sachi, et al.
Publicado: (2015)

COT-11 EFFECT OF PHYSICIAN SUPPORTS ON QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL BRAIN TUMOR RESEARCH
por: Furukawa, Keiko, et al.
Publicado: (2019)

COT-07 Cerebrovascular complications in adult patients with malignant brain tumor
por: Mineharu, Yohei, et al.
Publicado: (2020)

Impact of Intraoperative 3-Tesla MRI on Endonasal Endoscopic Pituitary Adenoma Resection and a Proposed New Scoring System for Predicting the Utility of Intraoperative MRI
por: TANJI, Masahiro, et al.
Publicado: (2020)

Preoperative obliteration of choroidal arteries in the treatment of large hypervascular tumors in the lateral ventricle
por: Yamao, Yukihiro, et al.
Publicado: (2021)

Jugular venous reflux on magnetic resonance angiography and radionuclide venography
por: Fushimi, Yasutaka, et al.
Publicado: (2016)

An Analysis of the Prognostic Value of IDH1 (Isocitrate Dehydrogenase 1) Mutation in Polish Glioma Patients
por: Lewandowska, Marzena Anna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_979jpfotb1r4palcefe3of5iqe